Clinical Trial

Insignia™ Hip Stem Outcomes Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-11-22; most recent amendment 2026-05-14.
Status change: Recruiting → Active, Not Recruiting 2024-05-16
Status change: Not Yet Recruiting → Recruiting 2022-03-29
Trial Details
NCT Number NCT05144191
Lead Sponsor Stryker Orthopaedics
Conditions Hip Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Post-traumatic Osteoarthritis, Femoral Neck Fractures, Trochanteric Fractures, Surgery
Enrollment 313 participants
Start Date 2022-02-07
Primary Completion 2034-04-02 (estimated)
Study Completion 2034-04-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-18